Page 13 - Clinical Programs News Today

It is with great sadness that his family reports the passing of John Ribble. His gentle wisdom, wry sense of humor and the loving kindness he shared will be deeply

For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.

A USAA-led initiative, with founding partners the Humana Foundation and Reach Resilience, gains steam to increase awareness of national crisis.

UConn Health is consolidating offices at its Brain & Spine Institute in a newly constructed building in Farmington, Conn. The project includes an additional $8.

The oldest advice in the financial markets is to buy low and sell high. The trick to winning, however, is to find the right stocks to buy, and to remember that ‘buy low’ doesn’t always mean these stocks can’t go lower. Sometimes the best bargains really do come in at the lowest prices. There are plenty of stocks under $10 that won’t break your bank and still offer substantial upside potential. How substantial? Well, the analysts at investment banking giant Oppe...

The National Bio Agro-defense Facility (NBAF) is partnering with Kansas State University, so researchers can get hands-on experience at the university's clinical skills lab.

TOPEKA (KSNT)- Kansas researchers are in the next phase of getting ready to study infectious diseases. The National Bio Agro-defense Facility (NBAF) is partnering with Kansas State University, so researchers can get hands-on experience at the university’s clinical skills lab. “They simulate the environment that individuals will be working in, but they focus on skill […]

Phase 3 LUMEOS clinical trial of botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) enrollment target has now been surpassedAnnounced positive clinical data from the completed AQUAx Phase 1 study of AAV2-hAQP1 for the treatment of grade 2/3 radiation-induced xerostomia (RIX), showing bilaterally treated participants reaching normal levels of whole saliva flow rate by 2 months post-treatment and persisting through the final Month 12

India clinical trial commences with first 30 cases 

An interdisciplinary faculty team from the College of Education and Health Professions is hosting an online professional development series for early career professionals called